Literature DB >> 12138243

Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary.

Hiroaki Itamochi1, Junzo Kigawa, Ryoji Akeshima, Shinya Sato, Shunji Kamazawa, Masakuni Takahashi, Yasunobu Kanamori, Mitsuaki Suzuki, Michitaka Ohwada, Naoki Terakawa.   

Abstract

Resistance of clear cell carcinoma (CCC) of the ovary to platinum-based chemotherapy is associated with a poor prognosis. However, the mechanism underlying the resistance of CCC to platinum has not yet been understood. We conducted the present study to clarify the mechanism of cisplatin (CDDP) resistance in CCC cells. Eleven CCC and 5 serous adenocarcinoma (SAC) cell lines were used in this study. The IC(50) to CDDP ranged from 1.3 to 18.0 microM for CCC cells and from 2.2 to 13.0 microM for SAC cells. There was no correlation between multidrug resistance-associated protein expression and the sensitivity to CDDP in CCC cells. In contrast, the doubling time for CCC cells was significantly longer than that for SAC cells (61.4 vs. 29.8 h). A significant reverse correlation between the S-phase fraction and the response to CDDP was observed (r = 0.647, p < 0.05). The present study suggests that the resistance of CCC to CDDP may be caused by low cell proliferation. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138243     DOI: 10.1159/000065067

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  12 in total

1.  Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.

Authors:  Hiroaki Itamochi; Misaki Kato; Mayumi Nishimura; Nao Oumi; Tetsuro Oishi; Muneaki Shimada; Shinya Sato; Jun Naniwa; Seiya Sato; Michiko Nonaka; Akiko Kudoh; Naoki Terakawa; Junzo Kigawa; Tasuku Harada
Journal:  Hum Cell       Date:  2013-02-21       Impact factor: 4.174

2.  Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression.

Authors:  Seiya Sato; Hiroaki Itamochi; Nao Oumi; Youhei Chiba; Tetsuro Oishi; Muneaki Shimada; Shinya Sato; Jun Chikumi; Michiko Nonaka; Akiko Kudoh; Hiroaki Komatsu; Tasuku Harada; Toru Sugiyama
Journal:  Hum Cell       Date:  2016-03-09       Impact factor: 4.174

3.  Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary.

Authors:  Hiroshi Kobayashi; Hiroshi Shigetomi; Chiharu Yoshimoto
Journal:  Oncol Lett       Date:  2015-05-26       Impact factor: 2.967

Review 4.  Molecular mechanisms of resistance and toxicity associated with platinating agents.

Authors:  Cara A Rabik; M Eileen Dolan
Journal:  Cancer Treat Rev       Date:  2006-11-03       Impact factor: 12.111

5.  Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.

Authors:  Jinhong Wang; Hai Xie; Feng Gao; Tingkun Zhao; Hongming Yang; Bai Kang
Journal:  Tumour Biol       Date:  2015-10-22

6.  Suppression of annexin A11 in ovarian cancer: implications in chemoresistance.

Authors:  Jin Song; Ie-ming Shih; Daniel W Chan; Zhen Zhang
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

7.  Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locus.

Authors:  V A L Tomlinson; H J Newbery; J H Bergmann; J Boyd; D Scott; N R Wray; G C Sellar; H Gabra; A Graham; A R W Williams; C M Abbott
Journal:  Br J Cancer       Date:  2007-04-17       Impact factor: 7.640

8.  Toward an understanding of the pathophysiology of clear cell carcinoma of the ovary (Review).

Authors:  Chiharu Uekuri; Hiroshi Shigetomi; Sumire Ono; Yoshikazu Sasaki; Miyuki Matsuura; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2013-08-28       Impact factor: 2.967

9.  A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens.

Authors:  I S Scott; T M Heath; L S Morris; S M Rushbrook; K Bird; S L Vowler; M J Arends; N Coleman
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

Review 10.  Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives.

Authors:  Shinya Matsuzaki; Kiyoshi Yoshino; Yutaka Ueda; Satoko Matsuzaki; Mamoru Kakuda; Akiko Okazawa; Tomomi Egawa-Takata; Eiji Kobayashi; Tadashi Kimura
Journal:  Cancer Cell Int       Date:  2015-12-15       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.